Transgenic study of energy homeostasis equation: Implications and confounding influences

FASEB Journal

Volumn 14, Issue 14, 2000, Pages 2158-2170

  Inui, Akio ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arcuate nucleus; Body mass; Melanocortin; Neuropeptide Y

Indexed keywords

AMPHETAMINE; CD11B ANTIGEN; CELL SURFACE RECEPTOR; COCAINE; CORTICOTROPIN RELEASING FACTOR; DNA; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; LEPTIN; LIPOPROTEIN LIPASE; MELANIN CONCENTRATING HORMONE; MELANOCORTIN; METALLOTHIONEIN; NEUROPEPTIDE Y; OREXIN; SEROTONIN; TRANSCRIPTION FACTOR;

ARCUATE NUCLEUS; BODY MASS; ENERGY; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; HOMEOSTASIS; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0033745973     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0291rev     Document Type: Review

References (189)

1. Neuroendocrine responses to starvation and weight loss
2. Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis
3. Positional cloning of the mouse obese gene and its human homologue
4. Identification and expression cloning of a leptin receptor, OB-R
5. Leptin and the regulation of body weight in mammals
6. Clinical review 94: What's in a name? In search of leptin's physiologic role
7. Brain peptides and obesity: Pharmacologic treatment
8. Obesity and the hypothalamus: Novel peptides for new pathways
9. Signals that regulate food intake and energy homeostasis
10. Unraveling the central nervous system pathways underlying responses to leptin
11. From lesions to leptin: Hypothalamic control of food intake and body weight
12. Feeding and body weight regulation by hypothalamic neuropeptides - Mediation of the actions of leptin
13. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
14. The MONA LISA hypothesis in the time of leptin
15. Effects of the obese gene product on body weight regulation in ob/ob mice
16. Weight-reducing effects of the plasma protein encoded by the obese gene
17. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
18. Adipogenesis and obesity: Rounding out the big picture
19. Leptin: The tale of an obesity gene
20. Obesity genes: Molecular and metabolic mechanisms
21. Obesity: Progress through genetic manipulation
22. Animal models of obesity
23. Opioids: First lessons from knockout mice
24. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission
25. Stress-axis, coping and dementia: Gene-manipulation studies
26. Genetically engineered neural transmission
27. Using gene knockout and transgenic techniques to study the physiology and pharmacology of beta3-adrenergic receptors
28. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: Insights from targeted mouse mutants
29. G protein-coupled receptors: Functional and mechanistic insights through altered gene expression
30. Brain melanocortin receptors: From cloning to function
31. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
32. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor
33. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur
34. The role of the agouti gene in the yellow obese syndrome
35. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
36. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
37. Independent and additive effects of central POMC and leptin pathways on murine obesity
38. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
39. Overexpression of Agrt leads to obesity in transgenic mice
40. The role of agouti-related protein in regulating body weight
41. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity
42. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism
43. Neuropeptide Y-induced feeding and its control
44. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
45. Serotonin, eating behavior, and fat intake
46. Pharmacology of ingestive behaviour
47. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice
48. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors
49. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
50. Enhanced aggressive behavior in mice lacking 5-HT1B receptor
51. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors
52. Characterization of melanin-concentrating hormone from rat hypothalamus
53. The melanin-concentrating hormone: From the peptide to the gene
54. A role for melanin-concentrating hormone in the central regulation of feeding behaviour
55. Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat
56. Mice lacking melanin-concentrating hormone are hypophagic and lean
57. Molecular cloning of a gene sequence regulated by nerve growth factor
58. Expression of VGF mRNA in the adult rat central nervous system
59. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance
60. Brown adipose tissue metabolism
61. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue
62. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia
63. Physiology of transgenic mice with brown fat ablation: Obesity is due to lowered body temperature
64. Temperature-dependent feeding: Lack of role for leptin and defect in brown adipose tissue-ablated obese mice
65. Adhesion molecules - Part II: Blood vessels and blood cells
66. A new class of obesity genes encodes leukocyte adhesion receptors
67. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice
68. Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene
69. Facilitative glucose transporters
70. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue
71. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4
72. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase
73. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes
74. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue, lipoprotein lipase
75. Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance
76. Why do we eat? A neural systems approach
77. Role of ARC NPY neurons in energy homeostasis
78. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity
79. Neuropeptide Y feeding receptors: Are multiple subtypes involved?
80. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
81. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
82. Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice
83. Response of neuropeptide Y-deficient mice to feeding effectors
84. Y-receptor subtypes - How many more?
85. A receptor subtype involved in neuropeptide-Y-induced food intake
86. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor
87. Role of the Y5 neuropeptide Y receptor in feeding and obesity
88. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice
89. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor
90. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
91. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor
92. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis
93. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal
94. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice
95. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior
96. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
97. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice
98. Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice
99. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
100. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
101. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides
102. Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice
103. Ectopic expression of the CRF-binding protein: Minor impact on HPA axis regulation but induction of sexually dimorphic weight gain
104. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice
105. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: The role of CRF2 receptors
106. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia
107. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress
108. Mice deficient for corticotropin-releasing hormone receptor-2
109. Deletion of Crhr2 reveals an anoxiolytic role for corticotropin-releasing hormone receptor-2
110. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene
111. Energy balance and lipid metabolism in transgenic mice bearing an antisense GCR gene construct
112. Adrenal steroid receptors: Interactions with brain neuropeptide systems in relation to nutrient intake and metabolism
113. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
114. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
115. A role for glucagon-like peptide-1 in the central regulation of feeding
116. Glucagon-like peptides
117. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat
118. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
119. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice
120. Effect of intravenous human gastrin-releasing peptide on food intake in humans
121. Blockade of brain bombesin/GRP receptors increases food intake in satiated rats
122. On the role of bombesin in homeostasis
123. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice
124. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity
125. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin
126. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
127. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
128. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
129. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
130. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
131. Targeted disruption of the tumor necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice
132. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese
133. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia
134. Novel molecular targets for the treatment of obesity
135. Clinical pharmacology of beta 3-adrenoceptors
136. Targeted disruption of the beta 3-adrenergic receptor gene
137. Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition
138. Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity
139. Cyclic AMP second messenger systems
140. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A
141. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
142. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotyloe?
143. Unusual behavioral phenotypes of inbred mouse strains
144. Mice, gene targeting and behaviour: More than just genetic background
145. Mutant mice and neuroscience: Recommendations concerning genetic background. Banbury Conference on genetic background in mice
146. Gene-targeting studies: New methods, old problems
147. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
148. Strain-dependent epithelial defects in mice lacking the EGF receptor
149. Synaptic plasticity, place cells and spatial memory: Study with second generation knockouts
150. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies
151. Genetics of mouse behavior: Interactions with laboratory environment
152. Testing the genetics of behavior in mice
153. Defense of differing body weight set-points in diet-induced obese and resistant rats
154. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats
155. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y
156. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides
157. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice
158. Life without leptin
159. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
160. Congenital leptin deficiency is associated with severe early-onset obesity in humans
161. A leptin missense mutation associated with hypogonadism and morbid obesity
162. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
163. The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes
164. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4
165. Altered striatal function in a mutant mouse lacking D1A dopamine receptors
166. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses
167. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity
168. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
169. Paternal versus maternal transmission of a stimulatory G-protein α subunit knockout produces opposite effects on energy metabolism
170. Germ-line transformation of mice
171. Repeat-induced gene silencing in mammals
172. Inducible gene targeting in mice
173. Transcriptional activation by tetracyclines in mammalian cells
174. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
175. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
176. Subregion- and cell type-restricted gene knockout in mouse brain
177. Current and potential drugs for treatment of obesity
178. Of mice and MEN: What transgenic models tell us about hypothalamic control of energy balance
179. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic
180. Feeding behavior in dopamine-deficient mice
181. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene
182. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice
183. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
184. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
185. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
186. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin
187. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein
188. Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene
189. Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase